Zdrowie i gospodarka · 04/11/1999

FDA Announces Submission of Proposal for Blood and Blood Components Information Collection for OMB Review

The Food and Drug Administration (FDA) is announcing that it has submitted a proposal for the collection of information related to Current Good Manufacturing Practices for Blood and Blood Components to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. The FDA is seeking public comment on this proposal.